Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引：0
|
作者：
van Drunen, C
Meltzer, EO
Bachert, C
Bousquet, J
Fokkens, WJ
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium
[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France
来源：
ALLERGY | 2005年 / 60卷
关键词：
mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.
引用
收藏
页码：5 / 19
页数：15
相关论文
共 50 条
  • [41] Clinical pharmacology, efficacy and safety of atazanavir: a review
    Bentue-Ferrer, Daniele
    Arvieux, Cedric
    Tribut, Olivier
    Ruffault, Annick
    Bellissant, Eric
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (11) : 1455 - 1468
  • [42] Comparative efficacy and safety of mometasone furoate dry powder inhaler and budesonide Turbuhaler®
    Carlsson, LG
    Edsbäcker, S
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (06) : 1332 - 1333
  • [43] LIMITED APPLICATION OF MOMETASONE FUROATE ON THE FACE AND INTERTRIGINOUS AREAS - ANALYSIS OF SAFETY AND EFFICACY
    LEBWOHL, M
    PEETS, E
    CHEN, V
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (11) : 830 - 831
  • [44] Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler®
    Bousquet, J
    D'Urzo, A
    Hebert, J
    Barraza, CH
    Boulet, LP
    Suárez-Chacón, R
    Harnest, U
    Lundbäck, B
    Morales, GM
    Nieminen, MM
    Nolop, KB
    Visser, S
    Lutsky, BN
    EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) : 808 - 816
  • [45] The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis:: a randomized, double-blind, placebo-controlled study
    Stjärne, P
    Blomgren, K
    Cayé-Thomasen, P
    Salo, S
    Soderstrom, T
    ACTA OTO-LARYNGOLOGICA, 2006, 126 (06) : 606 - 612
  • [46] A comparison of the efficacy of mometasone furoate nasal spray and fluticasone propionate nasal spray on nasal and ocular symptoms in seasonal allergic rhinitis
    Filipovic, M.
    Cekiae, S.
    ALLERGY, 2007, 62 : 228 - 228
  • [47] Efficacy of mometasone furoate nasal spray in seasonal allergic rhinitis according to baseline symptom severity
    Derebery, M. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S63 - S63
  • [48] The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma
    Meltzer, Eli O.
    Wenzel, Sally
    JOURNAL OF ASTHMA, 2006, 43 (10) : 765 - 772
  • [49] Efficacy and safety of desloratadine in combination with mometasone furoate in patients with moderate-to-severe SAR
    Grevers, G.
    Karmann, B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S64 - S64
  • [50] Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy
    Samanta, Debopam
    CHILDREN-BASEL, 2022, 9 (08):
12345